Synergistic Activity of IDH1 Inhibitor Bay-1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia

被引：0
|
作者：
Chaturvedi, Anuhar
Gupta, Charu
Goparaju, Ramya
Gabdoulline, Razif
Kaulfuss, Stefan
Gorlich, Kerstin
Schottmann, Renate
Panknin, Olaf
Wagner, Markus
Geffers, Robert
Ganser, Arnold
Thol, Felicitas
Jeffers, Michael
Haegebarth, Andrea
Heuser, Michael
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1352
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia
    Chaturvedi, Anuhar
    Gupta, Charu
    Gabdoulline, Razif
    Borchert, Nora M.
    Goparaju, Ramya
    Kaulfuss, Stefan
    Goerlich, Kerstin
    Schottmann, Renate
    Othman, Basem
    Welzenbach, Julia
    Panknin, Olaf
    Wagner, Markus
    Geffers, Robert
    Ganser, Arnold
    Thol, Felicitas
    Haegebarth, Andrea
    Jeffers, Michael
    Heuser, Michael
    HAEMATOLOGICA, 2021, 106 (02) : 565 - 573
  • [2] Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In Vivo
    Heuser, Michael
    Herbst, Lena
    Pusch, Stefan
    Klett, Lara
    Goparaju, Ramya
    Stichel, Damian
    Kaulfuss, Stefan
    Panknin, Olaf
    Zimmermann, Katja
    Toschi, Luisella
    Neuhaus, Roland
    Haegebarth, Andrea
    Rehwinkel, Hartmut
    Hess-Stumpp, Holger
    Bauser, Markus
    Bochtler, Tilmann
    Struys, Eduard A.
    Sharma, Amit
    Abdellatif, Abdellatif
    Geffers, Robert
    Cruz, Michelle M. Araujo
    Thol, Felicitas
    Gabdoulline, Razif
    Ganser, Arnold
    Ho, Anthony D.
    von Deimling, Andreas
    Rippe, Karsten
    Chaturvedi, Anuhar
    Kraemer, Alwin
    BLOOD, 2016, 128 (22)
  • [3] MRS BASED BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO THE IDH INHIBITOR BAY-1436032
    Hong, Donghyun
    Minami, Noriaki
    Taglang, Celine
    Batsios, Georgios
    Gillespie, Anne Marie
    Pieper, Russell
    Costello, Joseph
    Viswanath, Pavithra
    Ronen, Sabrina
    NEURO-ONCOLOGY, 2021, 23 : 173 - 173
  • [4] Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo
    Stefan Pusch
    Sonja Krausert
    Viktoria Fischer
    Jörg Balss
    Martina Ott
    Daniel Schrimpf
    David Capper
    Felix Sahm
    Jessica Eisel
    Ann-Christin Beck
    Manfred Jugold
    Viktoria Eichwald
    Stefan Kaulfuss
    Olaf Panknin
    Hartmut Rehwinkel
    Katja Zimmermann
    Roman C. Hillig
    Judith Guenther
    Luisella Toschi
    Roland Neuhaus
    Andrea Haegebart
    Holger Hess-Stumpp
    Markus Bauser
    Wolfgang Wick
    Andreas Unterberg
    Christel Herold-Mende
    Michael Platten
    Andreas von Deimling
    Acta Neuropathologica, 2017, 133 : 629 - 644
  • [5] Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
    Gupta, Charu
    Kaulfuss, Stefan
    Goerlich, Kerstin
    Othman, Basem
    Chaturvedi, Anuhar
    Heuser, Michael
    ANNALS OF HEMATOLOGY, 2020, 99 (06) : 1415 - 1417
  • [6] Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
    Charu Gupta
    Stefan Kaulfuss
    Kerstin Görlich
    Basem Othman
    Anuhar Chaturvedi
    Michael Heuser
    Annals of Hematology, 2020, 99 : 1415 - 1417
  • [7] Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo
    Pusch, Stefan
    Krausert, Sonja
    Fischer, Viktoria
    Balss, Joerg
    Ott, Martina
    Schrimpf, Daniel
    Capper, David
    Sahm, Felix
    Eisel, Jessica
    Beck, Ann-Christin
    Jugold, Manfred
    Eichwald, Viktoria
    Kaulfuss, Stefan
    Panknin, Olaf
    Rehwinkel, Hartmut
    Zimmermann, Katja
    Hillig, Roman C.
    Guenther, Judith
    Toschi, Luisella
    Neuhaus, Roland
    Haegebart, Andrea
    Hess-Stumpp, Holger
    Bauser, Markus
    Wick, Wolfgang
    Unterberg, Andreas
    Herold-Mende, Christel
    Platten, Michael
    von Deimling, Andreas
    ACTA NEUROPATHOLOGICA, 2017, 133 (04) : 629 - 644
  • [8] Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo
    A Chaturvedi
    L Herbst
    S Pusch
    L Klett
    R Goparaju
    D Stichel
    S Kaulfuss
    O Panknin
    K Zimmermann
    L Toschi
    R Neuhaus
    A Haegebarth
    H Rehwinkel
    H Hess-Stumpp
    M Bauser
    T Bochtler
    E A Struys
    A Sharma
    A Bakkali
    R Geffers
    M M Araujo-Cruz
    F Thol
    R Gabdoulline
    A Ganser
    A D Ho
    A von Deimling
    K Rippe
    M Heuser
    A Krämer
    Leukemia, 2017, 31 : 2020 - 2028
  • [9] Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo
    Chaturvedi, A.
    Herbst, L.
    Pusch, S.
    Klett, L.
    Goparaju, R.
    Stichel, D.
    Kaulfuss, S.
    Panknin, O.
    Zimmermann, K.
    Toschi, L.
    Neuhaus, R.
    Haegebarth, A.
    Rehwinkel, H.
    Hess-Stumpp, H.
    Bauser, M.
    Bochtler, T.
    Struys, E. A.
    Sharma, A.
    Bakkali, A.
    Geffers, R.
    Araujo-Cruz, M. M.
    Thol, F.
    Gabdoulline, R.
    Ganser, A.
    Ho, A. D.
    von Deimling, A.
    Rippe, K.
    Heuser, M.
    Kraemer, A.
    LEUKEMIA, 2017, 31 (10) : 2020 - 2028
  • [10] BAY 1436032: A highly selective, potent and orally available inhibitor of mutant forms of IDH1
    Panknin, Olaf
    Pusch, Stefan
    Herbst, Lena
    Kaulfuss, Stefan
    Zimmermann, Katja
    Rehwinkel, Hartmut
    Neuhaus, Roland
    Ring, Sven
    Bruning, Michael
    Stark, Claudia
    Prelle, Katja
    Michels, Martin
    Jeffers, Michael
    Hess-Stumpp, Holger
    Ziegelbauer, Karl
    Brands, Michael
    Kramer, Alwin
    von Deimling, Andreas
    CANCER RESEARCH, 2016, 76
12345